Loading
Latest filing published 21 May 2025 for Sharp Therapeutics Corp., €156k.
No signal scores available.
John J. Hathaway appears in our data through filings on Sharp Therapeutics Corp. shares, published by SEDI. Between 11 December 2024 and 22 April 2025, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 21 May 2025 with an option exercise (€156k) in Sharp Therapeutics Corp. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations